Expression and Purification of Matrix Metalloproteinases in Escherichia coli.

about

Expression and Purification of Matrix Metalloproteinases in Escherichia coli.

Item

http://www.wikidata.org/entity/Q51097581

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Expression and Purification of Matrix Metalloproteinases in Escherichia coli.

@en

Expression and Purification of Matrix Metalloproteinases in Escherichia coli.

@nl

type

Item

label

Expression and Purification of Matrix Metalloproteinases in Escherichia coli.

@en

Expression and Purification of Matrix Metalloproteinases in Escherichia coli.

@nl

prefLabel

Expression and Purification of Matrix Metalloproteinases in Escherichia coli.

@en

Expression and Purification of Matrix Metalloproteinases in Escherichia coli.

@nl

P1476

Expression and Purification of Matrix Metalloproteinases in Escherichia coli.

@en

P2093

Deepak K Saini

http://www.w3.org/2001/XMLSchema#string

Harini Ramanan

http://www.w3.org/2001/XMLSchema#string

Krishna K Singh

http://www.w3.org/2001/XMLSchema#string

Ruchi Jain

http://www.w3.org/2001/XMLSchema#string

P2860

Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

Cloning, overexpression, purification, and matrix-assisted refolding of DevS (Rv 3132c) histidine protein kinase of Mycobacterium tuberculosis

Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels

Structure and function of matrix metalloproteinases and TIMPs

Determination of protease cleavage site motifs using mixture-based oriented peptide libraries.

Fragmentation of fibronectin by inherent autolytic and matrix metalloproteinase activities.

Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.

Construction and deconstruction of bacterial inclusion bodies.

Metalloproteinase inhibitors: biological actions and therapeutic opportunities.

Practical considerations in refolding proteins from inclusion bodies.

P304

3-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/978-1-4939-6863-3_1

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

1579

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28299729

http://www.w3.org/2001/XMLSchema#string